专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20060223867A1 Cancer treatment with epothilones 失效
公开(公告)号：US20060223867A1
公开(公告)日：2006-10-05
申请号：US11406896
申请日：2006-04-19
申请人： Terence O'Reilly , Markus Wartmann , Manuel Litchman , Pamela Cohen
发明人： Terence O'Reilly , Markus Wartmann , Manuel Litchman , Pamela Cohen
IPC分类号： A61K31/427
CPC分类号： A61K31/425
摘要： The invention relates to the treatment of a proliferative disease, especially according to certain treatment regimens, with an epothilone, especially with epothilone A and more preferably epothilone B; as well as to the treatment of certain cancers with such an epothilone.

2. 发明申请

US20050165071A1 Cancer treatment with epothilones 失效
标题翻译：用埃坡霉素治疗癌症
公开(公告)号：US20050165071A1
公开(公告)日：2005-07-28
申请号：US11089269
申请日：2005-03-24
申请人： Terence O'Reilly , Markus Wartmann , Manuel Litchman , Pamela Cohen
发明人： Terence O'Reilly , Markus Wartmann , Manuel Litchman , Pamela Cohen
IPC分类号： C07D493/04 , A61K31/425 , A61K31/427 , A61P35/00
CPC分类号： A61K31/425
摘要： The invention relates to the treatment of a proliferative disease, especially according to certain treatment regimens, with an epothilone, especially with epothilone A and more preferably epothilone B; as well as to the treatment of certain cancers with such an epothilone.
摘要翻译：本发明涉及治疗增殖性疾病，特别是根据某些治疗方案，与埃坡霉素，特别是埃坡霉素A，更优选埃坡霉素B; 以及用这种埃坡霉素治疗某些癌症。

3. 发明授权

US07875601B2 Cancer treatment with epothilones 失效
标题翻译：用埃坡霉素治疗癌症
公开(公告)号：US07875601B2
公开(公告)日：2011-01-25
申请号：US11406896
申请日：2006-04-19
申请人： Terence O'Reilly , Markus Wartmann , Manuel Litchman , Pamela Cohen
发明人： Terence O'Reilly , Markus Wartmann , Manuel Litchman , Pamela Cohen
IPC分类号： A01N43/00 , A61K31/33
CPC分类号： A61K31/425
摘要： The invention relates to the treatment of a proliferative disease, especially according to certain treatment regimens, with an epothilone, especially with epothilone A and more preferably epothilone B; as well as to the treatment of certain cancers with such an epothilone.
摘要翻译：本发明涉及治疗增殖性疾病，特别是根据某些治疗方案，与埃坡霉素，特别是埃坡霉素A，更优选埃坡霉素B; 以及用这种埃坡霉素治疗某些癌症。

4. 发明授权

US06302838B1 Cancer treatment with epothilones 有权
标题翻译：用埃坡霉素治疗癌症
公开(公告)号：US06302838B1
公开(公告)日：2001-10-16
申请号：US09233993
申请日：1999-01-19
申请人： Terence O'Reilly , Markus Wartmann , Manuel Litchman , Pamela Cohen
发明人： Terence O'Reilly , Markus Wartmann , Manuel Litchman , Pamela Cohen
IPC分类号： A61K31425
CPC分类号： A61K31/425
摘要： The invention relates to the treatment of a proliferative disease, especially according to certain treatment regimens, with an epothilone, especially with epothilone A and more preferably epothilone B; as well as to the treatment of certain cancers with such an epothilone.
摘要翻译：本发明涉及治疗增殖性疾病，特别是根据某些治疗方案，与埃坡霉素，特别是埃坡霉素A，更优选埃坡霉素B; 以及用这种埃坡霉素治疗某些癌症。

5. 发明授权

US07091226B2 Cancer treatment with epothilones 失效
公开(公告)号：US07091226B2
公开(公告)日：2006-08-15
申请号：US11089269
申请日：2005-03-24
申请人： Terence O'Reilly , Markus Wartmann , Manuel Litchman , Pamela Cohen
发明人： Terence O'Reilly , Markus Wartmann , Manuel Litchman , Pamela Cohen
IPC分类号： A01N43/78 , A61K31/425
CPC分类号： A61K31/425
摘要： The invention relates to the treatment of a proliferative disease, especially according to certain treatment regimens, with an epothilone, especially with epothilone A and more preferably epothilone B; as well as to the treatment of certain cancers with such an epothilone.

6. 发明授权

US06635666B2 Cancer treatment with epothilones 失效
标题翻译：用埃坡霉素治疗癌症
公开(公告)号：US06635666B2
公开(公告)日：2003-10-21
申请号：US09925119
申请日：2001-08-09
申请人： Terence O'Reilly , Markus Wartmann , Manuel Litchman , Pamela Cohen
发明人： Terence O'Reilly , Markus Wartmann , Manuel Litchman , Pamela Cohen
IPC分类号： A61K31425
CPC分类号： A61K31/425
摘要： The invention relates to the treatment of a proliferative disease, especially according to certain treatment regimens, with an epothilone, especially with epothilone A and more preferably epothilone B; as well as to the treatment of certain cancers with such an epothilone.
摘要翻译：本发明涉及治疗增殖性疾病，特别是根据某些治疗方案，与埃坡霉素，特别是埃坡霉素A，更优选埃坡霉素B; 以及用这种埃坡霉素治疗某些癌症

7. 发明申请

US20090202541A1 COMBINATION COMPRISING N-{5-[4-(4-METHYL-PIPERAZINO-METHYL)-BENZOYLAMIDO]-2-METHYLPHENYL)-4-(3-PYRIDYL)-2PYRIMIDINE-AMINE AND A CHEMOTHERAPEUTIC AGENT 审中-公开
标题翻译：包含N- {5- [4-（4-甲基 - 哌嗪基 - 甲基） - 苯甲酰氨基] -2-甲基苯基）-4-（3-吡啶基）-2-嘧啶胺和化学代谢物的组合
公开(公告)号：US20090202541A1
公开(公告)日：2009-08-13
申请号：US12423079
申请日：2009-04-14
申请人： Christian Bruns , Elisabeth Buchdunger , Terence O'Reilly , Sandra Leta Silberman , Markus Wartmann , Gisbert Weckbecker
发明人： Christian Bruns , Elisabeth Buchdunger , Terence O'Reilly , Sandra Leta Silberman , Markus Wartmann , Gisbert Weckbecker
IPC分类号： A61K31/506 , A61K39/395 , A61K31/704 , A61P35/00
CPC分类号： A61K45/06 , A61K31/506
摘要： A method of treating a warm-blooded animal, especially a human, having a proliferative disease or acute or chronic transplant rejection comprising administering to the animal a combination which comprises (a) N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine and (b) a chemotherapeutic agent selected from antineoplastic agents, especially as defined herein, and agents effective in treating acute or chronic transplant rejection; a combination comprising (a) and (b) as defined above and optionally at least one pharmaceutically acceptable carrier for simultaneous, separate or sequential use, in particular for the delay of progression or treatment of a proliferative disease, especially a solid tumor disease.
摘要翻译：一种治疗具有增殖性疾病或急性或慢性移植排斥反应的温血动物，特别是人的方法，包括向动物施用包含（a）N- {5- [4-（4-甲基 - 哌嗪子基） - 甲基） - 苯甲酰氨基] -2-甲基苯基} -4-（3-吡啶基）-2-嘧啶胺和（b）选自抗肿瘤剂，特别是本文所定义的化学治疗剂和有效治疗急性或慢性的药物移植排斥反应包含如上定义的（a）和（b）和任选的至少一种用于同时，分开或顺序使用的药学上可接受的载体的组合，特别是用于延缓进展或治疗增殖性疾病，特别是实体肿瘤疾病。

8. 发明申请

US20120283206A1 Combination comprising N--4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent. 审中-公开
标题翻译：包含N-4-（3-吡啶基）-2嘧啶胺和化学治疗剂的组合。
公开(公告)号：US20120283206A1
公开(公告)日：2012-11-08
申请号：US13551079
申请日：2012-07-17
申请人： Christian Bruns , Elisabeth Buchdunger , Terence O'Reilly , Sandra Leta Siberman , Markus Wartmann , Gisbert Weckbecker
发明人： Christian Bruns , Elisabeth Buchdunger , Terence O'Reilly , Sandra Leta Siberman , Markus Wartmann , Gisbert Weckbecker
IPC分类号： A61K31/506 , A61K31/675 , A61P37/06 , A61K31/704 , A61P35/00
CPC分类号： A61K45/06 , A61K31/506
摘要： A method of treating a warm-blooded animal, especially a human, having a proliferative disease or acute or chronic transplant rejection comprising administering to the animal a combination which comprises (a) N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine and (b) a chemotherapeutic agent selected from antineoplastic agents, especially as defined herein, and agents effective in treating acute or chronic transplant rejection; a combination comprising (a) and (b) as defined above and optionally at least one pharmaceutically acceptable carrier for simultaneous, separate or sequential use, in particular for the delay of progression or treatment of a proliferative disease, especially a solid tumor disease.
摘要翻译：一种治疗具有增殖性疾病或急性或慢性移植排斥反应的温血动物，特别是人的方法，包括向动物施用包含（a）N- {5- [4-（4-甲基 - 哌嗪子基） - 甲基） - 苯甲酰氨基] -2-甲基苯基} -4-（3-吡啶基）-2-嘧啶胺和（b）选自抗肿瘤剂，特别是本文所定义的化学治疗剂和有效治疗急性或慢性的药物移植排斥反应包含如上定义的（a）和（b）和任选的至少一种用于同时，分开或顺序使用的药学上可接受的载体的组合，特别是用于延缓进展或治疗增殖性疾病，特别是实体肿瘤疾病。

9. 发明授权

US07723339B2 Combination comprising a signal transduction inhibitor and an epothilone derivative 失效
标题翻译：包含信号转导抑制剂和埃坡霉素衍生物的组合
公开(公告)号：US07723339B2
公开(公告)日：2010-05-25
申请号：US10469367
申请日：2002-02-26
申请人： Ralf Brandt , Elisabeth Buchdunger , Carl-Henrik Heldin , Arne Östman , Kristian Pietras , Terence O'Reilly , John D Rothermel , Peter Traxler , Markus Wartmann
发明人： Ralf Brandt , Elisabeth Buchdunger , Carl-Henrik Heldin , Arne Östman , Kristian Pietras , Terence O'Reilly , John D Rothermel , Peter Traxler , Markus Wartmann
IPC分类号： A61K31/497 , A61K31/425 , A01N43/78 , A01N43/54 , C07D239/42 , C07D401/04 , A61K31/435 , A01N43/40 , A61K31/505
CPC分类号： A61K31/505 , A61K31/425 , A61K45/06 , A61K31/435 , A61K2300/00
摘要： The present invention relates to a combination comprising N-{5-[4-(4-methyl-piperazino-methyl) -benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine and an epothiione derivative; pharmaceutical composition comprising said combination; method of treatment comprising said combination; and commercial packages comprising said combination.
摘要翻译：本发明涉及包含N- {5- [4-（4-甲基 - 哌嗪子基 - 甲基） - 苯甲酰氨基] -2-甲基苯基} -4-（3-吡啶基）-2-嘧啶胺和环硫代衍生物; 包含所述组合的药物组合物; 包括所述组合的处理方法; 以及包括所述组合的商业包装。

10. 发明申请

US20110033458A1 COMBINATIONS COMPRISING EPOTHILONES AND PHARMACEUTICAL USES THEREOF 审中-公开
标题翻译：包含EPOTHILONES及其药物用途的组合
公开(公告)号：US20110033458A1
公开(公告)日：2011-02-10
申请号：US12908533
申请日：2010-10-20
申请人： John Arthur Hohneker , Julie Ann Miller , John David Rothermel , Markus Wartmann
发明人： John Arthur Hohneker , Julie Ann Miller , John David Rothermel , Markus Wartmann
IPC分类号： A61K39/395 , A61K31/427 , A61P35/00
CPC分类号： C07K16/3015 , A61K31/426 , A61K31/427 , A61K39/39558 , A61K45/06 , A61K2039/505 , C07D417/06 , A61K2300/00
摘要： The invention relates to a pharmaceutical combination which comprises (a) a HER-1 or a HER-2 antibody or (b) at least one antineoplastic agent selected from the group consisting of aromatase inhibitors, antiestrogens, topoisomerase I inhibitors, topoisomerase II inhibitors, microtubule active agents, protein kinase C inhibitors, anti-angiogenic compounds, gonadorelin agonists, anti-androgens, histone deacetylase inhibitors and S-adenosylmethionine decarboxylase inhibitors; and (c) an epothilone derivative of formula I and optionally at least one pharmaceutically acceptable carrier for simultaneous, separate or sequential use, in particular, for the treatment of a proliferative disease, especially a solid tumor disease; a pharmaceutical composition comprising such a combination; the use of such a combination for the preparation of a medicament for the treatment of a proliferative disease; a commercial package or product comprising such a combination as a combined preparation for simultaneous, separate or sequential use; and to a method of treatment of a warm-blooded animal, especially a human.
摘要翻译：本发明涉及药物组合，其包含（a）HER-1或HER-2抗体或（b）至少一种抗肿瘤剂，其选自芳香酶抑制剂，抗雌激素，拓扑异构酶I抑制剂，拓扑异构酶II抑制剂，微管活性剂，蛋白激酶C抑制剂，抗血管生成化合物，促性腺激素激动剂，抗雄激素，组蛋白脱乙酰酶抑制剂和S-腺苷甲硫氨酸脱羧酶抑制剂; 和（c）式I的埃坡霉素衍生物和任选的至少一种用于同时，分别或顺序使用的药学上可接受的载体，特别是用于治疗增殖性疾病，特别是实体肿瘤疾病; 包含这种组合的药物组合物; 使用这种组合来制备用于治疗增殖性疾病的药物; 包括作为用于同时，分开或顺序使用的组合制剂的组合的商业包装或产品; 以及治疗温血动物，特别是人的方法。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式